Sen. Wyden Issues Statement on Future of Drug Pricing Legislation in Congress
June 30, 2020
June 30, 2020
WASHINGTON, June 30 -- Sen. Ron Wyden, D-Oregon, ranking Democratic member of the Senate Finance Committee, issued the following statement after Committee Chairman Chuck Grassley released an op-ed on drug pricing legislation, including claims that Democrats were no longer supporting the bill:
"Democrats have not walked away from the table on drug pricing - Republicans never showed up in the first place. The House passed a bill with Republican votes last year, while Mitch McConn . . .
"Democrats have not walked away from the table on drug pricing - Republicans never showed up in the first place. The House passed a bill with Republican votes last year, while Mitch McConn . . .